| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $2.3M | -65.0% |
| SG&A Expense | $946K | -76.0% |
| Operating Income | -$10.1M | +53.2% |
| Pre-tax Income | -$10.9M | +48.9% |
| Income Tax | $0 | — |
| Net Income | -$10.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $1.1M | -80.0% |
| Total Assets | $8.9M | +10.4% |
| Current Liabilities | $4.5M | +51.0% |
| Total Liabilities | $5.0M | +34.2% |
| Stockholders' Equity | $3.2M | -26.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | +8.2% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $5.7M | +16.2% |
| EPS (Basic) | -$5.65 | -580.7% |
| EPS (Diluted) | -$5.65 | -580.7% |